| Literature DB >> 16408224 |
Renée C Niessen1, Rolf H Sijmons, J Ou, Sandra G M Olthof, Jan Osinga, Marjolijn J Ligtenberg, Frans B L Hogervorst, Marjan M Weiss, Carli M J Tops, Frederik J Hes, Geertruida H de Bock, Charles H C M Buys, Jan H Kleibeuker, Robert M W Hofstra.
Abstract
Biallelic germline mutations of MUTYH-a gene encoding a base excision repair protein-are associated with an increased susceptibility of colorectal cancer. Whether monoallelic MUTYH mutations also increase cancer risk is not yet clear, although there is some evidence suggesting a slight increase of risk. As the MUTYH protein interacts with the mismatch repair (MMR) system, we hypothesised that the combination of a monoallelic MUTYH mutation with an MMR gene mutation increases cancer risk. We therefore investigated the prevalence of monoallelic MUTYH mutations in carriers of a germline MMR mutation: 40 carriers of a truncating mutation (group I) and 36 of a missense mutation (group II). These patients had been diagnosed with either colorectal or endometrial cancer. We compared their MUTYH mutation frequencies with those observed in a group of 134 Dutch colorectal and endometrial cancer patients without an MMR gene mutation (0.7%) and those reported for Caucasian controls (1.5%). In group I one monoallelic MUTYH mutation was found (2.5%). In group II five monoallelic germline MUTYH mutations were found (14%), four of them in MSH6 missense mutation carriers (20%). Of all patients with an MMR gene mutation, only those with a missense mutation showed a significantly higher frequency of (monoallelic) MUTYH mutations than the Dutch cancer patients without MMR gene mutations (P = 0.002) and the published controls (P = 0.001). These results warrant further study to test the hypothesis of mutations in MMR genes (in particular MSH6) and MUTYH acting together to increase cancer risk.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16408224 DOI: 10.1007/s00439-005-0118-5
Source DB: PubMed Journal: Hum Genet ISSN: 0340-6717 Impact factor: 4.132